Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
3
×
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aducanumab
bayer
biotech
clinical trials
deals
genentech
johnson & johnson
nash
ngm biopharmaceuticals
nonalcoholic steatohepatitis
starboard value
What
bio
3
×
drug
3
×
news
3
×
roundup
approved
biogen
nash
week
adu
aducanumab
alzheimer’s
amyloid
angst
bagged
beats
bids
billions
biogen’s
brammer
companies
complicated
depression
digital
dire
disease
effects
epidemic
failure
fatty
fda
felt
frenzied
good
group
growing
heart
help
known
led
liver
Language
Current search:
bio
×
drug
×
news
×
celgene
×
" life sciences "
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More